Gurjit Singh credits the Mitacs Elevate program with facilitating the transition point between postdoctoral education and finding a fulfilling research position. He obtained his Ph.D. (psychology) from the University of Toronto, his M.A. (social psychology) from the University of Waterloo, and his M.Sc. (Audiology) from Western University.
“The Mitacs Elevate program helped prepare me for a career where I’d be merging ideas and leveraging the abilities of people with seemingly divergent skill sets and disparate backgrounds. I feel like I’m much better prepared to coordinate projects that involve balancing the different expectations of clinical, academic, and industrial partners. I have been given the tools that will allow me to manage diverse stakeholder interests while maintaining a focus on our common goals.”
“I thought I might benefit from learning a little bit more about the business environment, but I didn’t have very high expectations about the workshops themselves,” El Saadany says. It turned out his expectations were to be exceeded by far. In the end, El Saadany took part in half a dozen different Mitacs Step skills development workshops.
Optimization techniques, an emerging innovation, can serve as one of the tools for financial institutions and companies to find better solutions and improve decision-making. With this focus, Mitacs Elevate Fellow Oleksandr Romanko created an industry-academic event called ‘Optimization in Finance and Risk Management’.
“I’m learning a lot,” says Amit Badlani, a Mitacs Globalink program participant from India doing a research internship at Carleton University in Ottawa. “I honestly didn’t think I would get so much out of this.”
Through the support of Mitacs Accelerate, John Ashley Scott, a professor of biochemical engineering at Laurentian University, and Greg Ross, associate dean of research at the Northern Ontario School of Medicine were able to assemble a multi-disciplinary, multi-company research venture undertaken by seven Mitacs Accelerate interns.
One of the most talked-about biomedical breakthroughs of 2010, this new development offers hope to sufferers of blood and immunological diseases, such as leukemias, who are often unable to find a suitable donor.